NYSE:SLB • AN8068571086
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for SLB LTD (SLB).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-04 | Goldman Sachs | Maintains | Buy -> Buy |
| 2026-02-02 | Jefferies | Maintains | Buy -> Buy |
| 2026-01-26 | BMO Capital | Maintains | Outperform -> Outperform |
| 2026-01-26 | RBC Capital | Maintains | Outperform -> Outperform |
| 2026-01-26 | Susquehanna | Maintains | Positive -> Positive |
| 2026-01-26 | Barclays | Maintains | Overweight -> Overweight |
| 2026-01-26 | JP Morgan | Maintains | Overweight -> Overweight |
| 2026-01-26 | B of A Securities | Maintains | Buy -> Buy |
| 2026-01-26 | Citigroup | Maintains | Buy -> Buy |
| 2026-01-21 | Stifel | Maintains | Buy -> Buy |
| 2026-01-07 | Susquehanna | Maintains | Positive -> Positive |
| 2026-01-06 | Freedom Capital Markets | Downgrade | Buy -> Hold |
| 2026-01-06 | Evercore ISI Group | Upgrade | In-Line -> Outperform |
| 2025-12-18 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-12-17 | Barclays | Maintains | Overweight -> Overweight |
| 2025-12-12 | UBS | Maintains | Buy -> Buy |
| 2025-12-11 | TD Cowen | Maintains | Buy -> Buy |
| 2025-12-11 | Bernstein | Maintains | Outperform -> Outperform |
| 2025-12-11 | Citigroup | Maintains | Buy -> Buy |
| 2025-11-03 | Rothschild & Co | Initiate | Buy |
| 2025-10-21 | Barclays | Maintains | Overweight -> Overweight |
| 2025-10-21 | Citigroup | Maintains | Buy -> Buy |
| 2025-10-20 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-10-16 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2025-08-20 | Melius Research | Initiate | Buy |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 33.135B 17.96% | 36.289B 9.52% | 35.708B -1.60% | 37.649B 5.44% | 39.374B 4.58% | 41.103B 4.39% | 41.207B 0.25% | 42.158B 2.31% | |
| EBITDA YoY % growth | 7.811B 24.02% | 8.888B 13.79% | 8.267B -6.99% | 9.007B 8.95% | 9.657B 7.22% | 10.302B 6.68% | 10.122B -1.75% | 10.39B 2.65% | |
| EBIT YoY % growth | 5.499B 32.47% | 6.369B 15.82% | 5.624B -11.70% | 6.244B 11.02% | 6.855B 9.79% | 7.345B 7.15% | 7.356B 0.15% | 7.468B 1.52% | |
| Operating Margin | 16.60% | 17.55% | 15.75% | 16.58% | 17.41% | 17.87% | 17.85% | 17.71% | |
| EPS YoY % growth | 2.99 37.16% | 3.41 14.05% | 2.93 -14.08% | 2.94 0.49% | 3.40 15.62% | 3.79 11.48% | 3.95 4.07% | 3.97 0.64% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.61 -14.98% | 0.69 -7.23% | 0.76 9.89% | 0.82 5.18% | 0.72 17.78% | 0.79 14.82% | 0.85 12.07% | 0.91 10.98% | 0.81 12.35% | 0.88 11.09% | 0.93 9.59% |
| Revenue Q2Q % growth | 8.974B 5.70% | 9.198B 7.63% | 9.503B 6.44% | 9.829B 0.86% | 9.441B 5.20% | 9.599B 4.36% | 10.05B 5.76% | 10.434B 6.16% | N/A | N/A | N/A |
| EBITDA Q2Q % growth | 2.024B -0.10% | 2.158B -18.66% | 2.282B -32.28% | 2.392B -40.81% | 2.221B 9.73% | 2.357B 9.22% | 2.437B 6.79% | 2.544B 6.35% | 2.377B 7.02% | 2.493B 5.77% | 2.592B 6.36% |
| EBIT Q2Q % growth | 1.31B -5.48% | 1.431B 3.70% | 1.562B 7.06% | 1.68B 20.17% | 1.511B 15.34% | 1.678B 17.26% | 1.744B 11.65% | 1.818B 8.21% | N/A | N/A | N/A |
All data in USD
33 analysts have analysed SLB and the average price target is 55.75 USD. This implies a price increase of 18.15% is expected in the next year compared to the current price of 47.19.
SLB LTD (SLB) will report earnings on 2026-04-23, before the market open.
The consensus EPS estimate for the next earnings of SLB LTD (SLB) is 0.61 USD and the consensus revenue estimate is 8.97B USD.
The consensus rating for SLB LTD (SLB) is 81.8182 / 100 . This indicates that analysts generally have a positive outlook on the stock.